• Have a question?
    Open from 8am to 7pm Monday to Friday
    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print


Legal & General Ucits Etf Public Limited Company L&G PHARMA BREAKTHROUGH GO UCITS ETF

Sell: $9.843|Buy: $9.913|Change: 0.04 (0.45%)

Open 

$9.83


Previous close 

$9.8335


Trade high 

$9.905


Year low 

$9.39


Year high 

$12.70


Replication method 

Physical Full


Volume 

89,220


Type 

ETF


UCITS 

Yes


Dividend yield 

-


Ongoing charge 

0.49


ISIN 

IE00BF0H7608


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Before investing please read:

Key Investor Information Document (KIID)

Performance 29/02/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Fund+ 0.45
Category-
More...

Investment objective

The investment objective of the Fund is to provide exposure to bio-technology companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. In order to achieve this investment objective, the Fund will seek to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the “Index”). It will do so by investing primarily in a portfolio of equity securities that, as far as possible and practicable, consists of the component securities of the Index in similar proportions to their weightings in the Index and may have exposure to or invest directly up to 20% of its Net Asset Value in shares issued by the same body, which limit may be raised to 35% for a single issuer in exceptional market conditions, including (but not limited to) circumstances in which such issuer occupies a dominant market position.

Asset class

ETF

Morningstar ratingTM


Morningstar sustainability ratingTM


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.